Douglas Bakan
Chief Tech/Sci/R&D Officer en ARENA PHARMACEUTICALS .
Perfil
Douglas A.
Bakan is currently the Vice President-Technical Operations at Arena Pharmaceuticals, Inc. Prior to this, he held positions such as Director-Product Development at Molecular Biosystems, Inc., Senior Director-Development at Neurocrine Biosciences, Inc., Manufacturing Director at Corvas International, Inc., Vice President-Product Development at Novalar Pharmaceuticals, Inc., Vice President-Business Development at Alerion Biomedical, Inc., and Chief Operating Officer at Metaprobe LLC.
Bakan received his undergraduate and doctorate degrees from the University of California San Diego.
Cargos activos de Douglas Bakan
Empresas | Cargo | Inicio |
---|---|---|
ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Douglas Bakan.
Empresas | Cargo | Fin |
---|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Corvas International, Inc. | Corporate Officer/Principal | - |
Metaprobe LLC | Chief Operating Officer | - |
NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formación de Douglas Bakan.
University of California San Diego | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Corvas International, Inc. | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Alerion Biomedical, Inc.
Alerion Biomedical, Inc. Medical SpecialtiesHealth Technology Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA. | Health Technology |
Metaprobe LLC |
- Bolsa de valores
- Insiders
- Douglas Bakan